[ Price : $8.95]
CDRH schedules a public meeting at which to receive input on how it can better adapt to using new science in regulatory decisions.[ Price : $8.95]
Reuters reports that many drug companies in the U.S. and Europe are cutting the number of sales reps as doctors lose influence ove...[ Price : $8.95]
Federal Register Notice: FDA releases an ICH draft guidance, Q4B Evaluation and Recommendation of Pharmacopeial Texts for Use in t...[ Price : $8.95]
Federal Register Notice: FDA releases an ICH draft guidance, Q4B Evaluation and Recommendation of Pharmacopeial Texts for Use in t...[ Price : $8.95]
Federal Register Notice: FDAs Oncologic Drugs Advisory Committee will meet 2/10 to discuss Cell Therapeutics NDA for Pixuvri to tr...[ Price : $8.95]
Federal Register Notice: FDA Florida District and the Society of Clinical Research Associates will hold a public workshop 3/3-4/10...[ Price : $8.95]
Auxilium says it plans to meet with FDA in the second quarter of next year to review recent Phase 2 data and discuss a Phase 3 cli...[ Price : $8.95]
Federal Register Final rule: FDA amends the animal drug regulations to change a sponsor for ketamine HCl to Bioniche Teoranta.